Home > Financial Ratios > LYKA LABS

LYKA LABS
Cash Earnings per Share (CEPS)

    Back to All Ratios
AD     Remove this Ad

LYKA LABS Last 5 Year Cash Earnings per Share (CEPS) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   CEPS(Rs) 4.123.080.3219.45-0.62

What is the latest Cash Earnings per Share (CEPS) ratio of LYKA LABS ?

The latest Cash Earnings per Share (CEPS) ratio of LYKA LABS is 4.12 based on Mar2025 Consolidated results.
Year Cash Earnings per Share (CEPS)
Mar20254.12
Mar20243.08
Mar20230.32
Mar202219.45
Mar2021-0.62

How is Cash Earnings per Share (CEPS) of LYKA LABS Trending?

Years Cash Earnings per Share (CEPS) % Change
Mar2025 4.12
33.77
Mar2024 3.08
862.50
Mar2023 0.32
-98.35
Mar2022 19.45
Positive
Mar2021 -0.62 -

Other Financial Ratios of LYKA LABS


Compare Cash Earnings per Share (CEPS) ratio of peers of LYKA LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LYKA LABS ₹197.4 Cr 3.6% -17.6% -47.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,470.0 Cr -0.3% 3.1% 2.2% Stock Analytics
DIVIS LABORATORIES ₹161,996.0 Cr 0.5% -2.9% 5.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,440.0 Cr 0.1% 1.4% 37.6% Stock Analytics
DR REDDYS LABORATORIES ₹108,417.0 Cr 1.9% 1.4% 10.7% Stock Analytics
CIPLA ₹101,445.0 Cr -3.3% -6.9% -17% Stock Analytics


LYKA LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LYKA LABS

3.6%

-17.6%

-47.6%

SENSEX

-0%

-10.7%

1%


You may also like the below Video Courses